APA (7th ed.) Citation

Hullon, D., Subeh, G. K., Volkova, Y., Janiec, K., Trach, A., & Mnevets, R. (2025). The role of glucagon-like peptide-1 receptor (GLP-1R) agonists in enhancing endothelial function: A potential avenue for improving heart failure with preserved ejection fraction (HFpEF). Cardiovascular Diabetology, 24(1), 1. https://doi.org/10.1186/s12933-025-02607-w

Chicago Style (17th ed.) Citation

Hullon, Darshan, Ghasaq K. Subeh, Yelizaveta Volkova, Karolina Janiec, Adam Trach, and Ruslan Mnevets. "The Role of Glucagon-like Peptide-1 Receptor (GLP-1R) Agonists in Enhancing Endothelial Function: A Potential Avenue for Improving Heart Failure with Preserved Ejection Fraction (HFpEF)." Cardiovascular Diabetology 24, no. 1 (2025): 1. https://doi.org/10.1186/s12933-025-02607-w.

MLA (9th ed.) Citation

Hullon, Darshan, et al. "The Role of Glucagon-like Peptide-1 Receptor (GLP-1R) Agonists in Enhancing Endothelial Function: A Potential Avenue for Improving Heart Failure with Preserved Ejection Fraction (HFpEF)." Cardiovascular Diabetology, vol. 24, no. 1, 2025, p. 1, https://doi.org/10.1186/s12933-025-02607-w.